10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

Quarterly Report Pursuant To Section 13 Or 15(d) Of The

Securities Exchange Act of 1934

For the quarter ended September 30, 2014

Commission file number 000-21129

	AWARE, INC.
(Exact Name of Registrant as Specified in Its Charter)

	Massachusetts		04-2911026
(State or Other Jurisdiction of  Incorporation or Organization)		(I.R.S. Employer Identification No.)

	40 Middlesex Turnpike, Bedford, Massachusetts, 01730
(Address of Principal Executive Offices) (Zip Code)

	(781) 276-4000
(Registrant’s Telephone Number, Including Area Code)

Indicate by check whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

YES x  NO o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  YES x NO o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See definition of “large accelerated filer”, “accelerated filer”, and “smaller reporting company” in Rule 12b-2 of the Exchange Act.  (Check one):

Large Accelerated Filer o    Accelerated Filer x   Non-Accelerated Filer o Smaller Reporting Company o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  YES o   NO  x

Indicate the number of shares outstanding of the issuer’s common stock as of October 20, 2014:

	Class		Number of Shares Outstanding
Common Stock, par value $0.01 per share		22,804,720 shares

AWARE, INC.

FORM 10-Q

FOR THE QUARTER ENDED SEPTEMBER 30, 2014

TABLE OF CONTENTS

		Page
PART I	FINANCIAL INFORMATION
Item 1.	Unaudited Consolidated Financial Statements
	Consolidated Balance Sheets as of September 30, 2014 and December 31, 2013	3
	Consolidated Statements of Income and Comprehensive Income for the Three and Nine Months Ended September 30, 2014 and September 30, 2013	4
	Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2014 and September 30, 2013	5
	Notes to Consolidated Financial Statements	6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	12
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	19
Item 4.	Controls and Procedures	19
PART II	OTHER INFORMATION
Item 1.	Legal Proceedings	20
Item 1A.	Risk Factors	20
Item 4.	Mine Safety Disclosures	20
Item 6.	Exhibits	21
	Signatures	21

2

PART 1. FINANCIAL INFORMATION

ITEM 1: CONSOLIDATED FINANCIAL STATEMENTS

AWARE, INC.

CONSOLIDATED BALANCE SHEETS

(in thousands, except share data)

(unaudited)

	September 30, 2014			December 31, 2013
ASSETS
Current assets:
Cash and cash equivalents	$	43,507		$	72,660
Accounts receivable, net		3,950			4,582
Inventories		2			1,601
Deferred tax assets		214			383
Prepaid expenses and other current assets		435			695
Total current assets		48,108			79,921
Property and equipment, net		5,374			5,582
Investments		1,362			2,754
Long term deferred tax assets		729			762
Other assets		225			310
Total assets	$	55,798		$	89,329
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	179		$	1,516
Accrued expenses		100			108
Accrued compensation		600			571
Accrued professional		155			118
Accrued income taxes		57			-
Deferred revenue		2,622			1,848
Total current liabilities		3,713			4,161
Long-term deferred revenue		76			18
Commitments and contingent liabilities
Stockholders’ equity:
Preferred stock, $1.00 par value; 1,000,000 shares authorized, none outstanding		-			-
Common stock, $.01 par value; 70,000,000 shares authorized; issued and outstanding 22,804,720 as of September 30, 2014 and 22,574,251 as of December 31, 2013		228			226
Additional paid-in capital		103,657			101,293
Accumulated other comprehensive loss		(71	)		(125	)
Accumulated deficit		(51,805	)		(16,244	)
Total stockholders’ equity		52,009			85,150
Total liabilities and stockholders’ equity	$	55,798		$	89,329

The accompanying notes are an integral part of the consolidated financial statements.

3

AWARE, INC.

CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME

 (in thousands, except per share data)

(unaudited)

	Three Months Ended September 30,						Nine Months Ended September 30,
	2014			2013			2014			2013
Revenue:
Software licenses	$	3,077		$	2,268		$	6,759		$	6,860
Software maintenance		1,085			933			3,282			2,914
Services		1,585			943			3,931			2,080
Hardware sales		132			-			4,813			1,129
Royalties		148			170			626			737
Total revenue		6,027			4,314			19,411			13,720
Costs and expenses:
Cost of hardware sales		90			-			3,403			813
Cost of services		615			494			1,697			1,035
Research and development		1,381			1,043			4,060			3,042
Selling and marketing		973			817			2,813			2,466
General and administrative		940			922			2,719			2,580
Total costs and expenses		3,999			3,276			14,692			9,936
Patent related income		2,127			-			2,127			780
Operating income		4,155			1,038			6,846			4,564
Other income (expense)		-			27			(59	)		27
Interest income		43			80			182			239
Income from continuing operations before income taxes		4,198			1,145			6,969			4,830
Provision for income taxes		1,599			355			2,625			1,603
Income from continuing operations		2,599			790			4,344			3,227
Loss from discontinued operations, net of income taxes		-			(1,943	)		-			(2,216	)
Net income (loss)	$	2,599		($	1,153	)	$	4,344		$	1,011
Basic net income (loss) per share:
Basic net income per share from continuing operations	$	0.11		$	0.04		$	0.19		$	0.14
Basic net loss share from discontinued operations		0.00			(0.09	)		0.00			(0.10	)
Basic net income (loss) per share	$	0.11		($	0.05	)	$	0.19		$	0.04
Diluted net income (loss) per share:
Diluted net income per share from continuing operations	$	0.11		$	0.04		$	0.19		$	0.14
Diluted net loss per share from discontinued operations		0.00			(0.09	)		0.00			(0.10	)
Diluted net income (loss) per share	$	0.11		($	0.05	)	$	0.19		$	0.04
Weighted-average shares - basic		22,804			22,571			22,687			22,533
Weighted-average shares - diluted		22,893			22,571			22,781			22,623
Comprehensive income (loss):
Net income (loss)	$	2,599		($	1,153	)	$	4,344		$	1,011
Other comprehensive income (net of tax):
Unrealized gains (losses) on available for sale securities		(67	)		(26	)		54			(6	)
Comprehensive income (loss)	$	2,532		($	1,179	)	$	4,398		$	1,005

The accompanying notes are an integral part of the consolidated financial statements.

4

AWARE, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(unaudited)

	Nine Months Ended
	September 30,
	2014			2013
Cash flows from operating activities:
Net income	$	4,344		$	1,011
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		405			325
Stock-based compensation		619			445
Gain on sale of patent assets		(2,127	)		-
Deferred tax provision on other comprehensive income		(44	)		-
(Gain) loss on sale of investments		59			(27	)
Loss on disposal of property and equipment		-			27
Amortization of premium/(discount) on investments		(1	)		13
Changes in assets and liabilities:
Accounts receivable		632			703
Receivable from patent arrangement		-			1,121
Inventories		1,599			-
Prepaid expenses and other current assets		260			(565	)
Deferred tax assets		202			185
Accounts payable		(1,337	)		(85	)
Accrued expenses, compensation, and professional		58			(261	)
Accrued income taxes		57			-
Due to customers		-			3,732
Deferred revenue		832			(954	)
Net cash provided by operating activities		5,558			5,670
Cash flows from investing activities:
Purchases of property and equipment		(112	)		(117	)
Proceeds from the sale of property and equipment		-			24
Purchases of investments		-			(2,008	)
Sales of investments		1,432			1,064
Proceeds from sale of patent assets, net		2,127			-
Purchase of other assets		-			(201	)
Net cash provided by (used in) investing activities		3,447			(1,238	)
Cash flows from financing activities:
Proceeds from issuance of common stock		491			46
Payment of dividends		(39,905	)		-
Excess tax benefits from stock-based compensation		1,461			(63	)
Payments made for taxes of employees who surrendered shares related to unrestricted stock		(205	)		(71	)
Net cash used in financing activities		(38,158	)		(88	)
Increase/(decrease) in cash and cash equivalents		(29,153	)		4,344
Cash and cash equivalents, beginning of period		72,660			71,074
Cash and cash equivalents, end of period	$	43,507		$	75,418
Supplemental disclosure:     Cash paid for income taxes	$	617		$	535

The accompanying notes are an integral part of the consolidated financial statements.

5

AWARE, INC.

NOTES TO CONSOLIDATEDFINANCIAL STATEMENTS

(unaudited)

A) Basis of Presentation. The accompanying unaudited consolidated financial statements have been prepared in accordance with the instructions for Form 10-Q and therefore do not include all information and notes necessary for a complete presentation of our financial position, results of operations and cash flows, in conformity with generally accepted accounting principles.  We filed audited financial statements which included all information and notes necessary for such presentation for the three years ended December 31, 2013 in conjunction with our 2013 Annual Report on Form 10-K. This Form 10-Q should be read in conjunction with that Form 10-K.

The accompanying unaudited consolidated balance sheets, statements of income and comprehensive income, and statements of cash flows reflect all adjustments (consisting only of normal recurring items) which are, in the opinion of management, necessary for a fair presentation of financial position at September 30, 2014, and of operations and cash flows for the interim periods ended September 30, 2014 and 2013.

The results of operations for the interim period ended September 30, 2014 are not necessarily indicative of the results to be expected for the year.

B) Fair Value Measurements. The Financial Accounting Standards Board (“FASB”) Codification defines fair value, and establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to the unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). The three levels of the fair value hierarchy under the FASB Codification are: i) Level 1 – valuations that are based on quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date; ii) Level 2 – valuations that are based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly; and iii) Level 3 – valuations that require inputs that are both significant to the fair value measurement and unobservable.

Cash and cash equivalents, which primarily include money market mutual funds, were $43.5 million and $72.7 million as of September 30, 2014 and December 31, 2013, respectively. We classified our cash equivalents of $34.3 million and $68.6 million as of September 30, 2014 and December 31, 2013 within Level 1 of the fair value hierarchy because they are valued using quoted market prices.

Our investments, which consist of high yield corporate debt securities, are also classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices. We categorize our investments as available-for-sale securities, and carry them at fair value in our financial statements.  We had $1.4 million and $2.8 million of available-for-sale investments as of September 30, 2014 and December 31, 2013, respectively.

As of September 30, 2014, our assets that are measured at fair value on a recurring basis and whose carrying values approximate their respective fair values include the following (in thousands):

	Fair Value Measurement at September 30, 2014 Using:
	Quoted Prices in Active Markets for Identical Assets		Significant Other Observable Inputs		Significant Unobservable Inputs
	(Level 1)		(Level 2)		(Level 3)
Corporate debt securities	$	1,362	$	-	$	-
Money market funds (included in cash and cash equivalents)		34,289
Total	$	35,651	$	-	$	-

6

As of December 31, 2013, our assets that are measured at fair value on a recurring basis and whose carrying values approximate their respective fair values include the following (in thousands):

	Fair Value Measurement at December 31, 2013 Using:
	Quoted Prices in Active Markets for Identical Assets		Significant Other Observable Inputs		Significant Unobservable Inputs
	(Level 1)		(Level 2)		(Level 3)
Corporate debt securities	$	2,754	$	-	$	-
Money market funds (included in cash and cash equivalents)		68,556
Total	$	71,310	$	-	$	-

C)   Inventories. Inventories are stated at the lower of cost or net realizable value with cost being determined by the first-in, first-out (“FIFO”) method.  Inventories consisted of the following (in thousands):

	September 30, 2014		December 31, 2013
Raw materials	$	2	$	1,584
Finished goods		-		17
Total	$	2	$	1,601

D) Computation of Earnings per Share. Basic earnings per share is computed by dividing net income or loss by the weighted average number of common shares outstanding.  Diluted earnings per share is computed by dividing net income or loss by the weighted average number of common shares outstanding plus additional common shares that would have been outstanding if dilutive potential common shares had been issued.  For the purposes of this calculation, stock options are considered common stock equivalents in periods in which they have a dilutive effect.  Stock options that are anti-dilutive are excluded from the calculation.

Net income per share is calculated as follows (in thousands, except per share data):

	Three Months Ended September 30,					Nine Months Ended September 30,
	2014		2013			2014		2013
Net income:
Income from continuing operations	$	2,599	$	790		$	4,344	$	3,227
Loss from discontinued operations		-		(1,943	)		-		(2,216	)
Net income (loss)	$	2,599	$	(1,153	)	$	4,344	$	1,011
Shares outstanding:
Weighted-average common shares outstanding		22,804		22,571			22,687		22,533
Additional dilutive common stock equivalents		89		-			94		90
Diluted shares outstanding		22,893		22,571			22,781		22,623
Basic net income (loss) per share:
Basic net income per share from continuing operations	$	0.11	$	0.04		$	0.19	$	0.14
Basic net loss per share from discontinued operations		0.00		(0.09	)		0.00		(0.10	)
Basic net income (loss) per share	$	0.11	$	(0.05	)	$	0.19	$	0.04
Diluted net income (loss) per share:
Diluted net income per share from continuing operations	$	0.11	$	0.04		$	0.19	$	0.14
Diluted net loss per share from discontinued operations		0.00		(0.09	)		0.00		(0.10	)
Diluted net income (loss) per share	$	0.11	$	(0.05	)	$	0.19	$	0.04

7

For the three month period ended September 30, 2013, common stock equivalents of 111,349 were not included in the per share calculation for diluted EPS, because we had a net loss and the effect of their inclusion would be anti-dilutive.

For the three month periods ended September 30, 2014 and 2013, options to purchase 40,834 and 825,338 shares of common stock, respectively, were outstanding, but were not included in the computation of diluted EPS because the options’ exercise prices were greater than the average market price of the common stock and thus would be anti-dilutive.

For the nine month periods ended September 30, 2014 and 2013, options to purchase 40,834 and 825,338 shares of common stock, respectively, were outstanding, but were not included in the computation of diluted EPS because the options’ exercise prices were greater than the average market price of the common stock and thus would be anti-dilutive.

E) Stock-Based Compensation.  The following table presents stock-based employee compensation expenses included in our unaudited consolidated statements of comprehensive income (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2014		2013		2014		2013
Cost of services	$	15	$	12	$	30	$	23
Research and development		34		26		71		53
Selling and marketing		6		5		12		10
General and administrative		242		174		506		359
Stock-based compensation expense	$	297	$	217	$	619	$	445

Stock Option and SAR Grants. We grant stock options and stock appreciation rights (“SARs”) under our 2001 Nonqualified Stock Plan. We estimate the fair value of stock options and SARs using the Black-Scholes valuation model. This valuation model takes into account the exercise price of the award, as well as a variety of significant assumptions. The assumptions used to estimate the fair value of stock options and SARs include the expected term, the expected volatility of our stock over the expected term, the risk-free interest rate over the expected term, and our expected annual dividend yield. We believe that the valuation technique and the approach utilized to develop the underlying assumptions are appropriate in calculating the fair values of our stock options and SARs. Estimates of fair value are not intended to predict actual future events or the value ultimately realized by persons who receive equity awards.

Unrestricted Stock Grants. We also grant unrestricted shares of stock under our 2001 Nonqualified Stock Plan. Stock-based compensation expense for stock grants is determined based on the fair market value of our stock on the date of grant, provided the number of shares in the grant is fixed on the grant date.

Stock Option and SAR Grant Activity. We did not grant any stock options or SARs in the three and nine month periods ended September 30, 2014 and 2013.

Unrestricted Stock Grant Activity. We granted shares of unrestricted stock in 2014 and 2013 that affected financial results for the three and nine month periods ended September 30, 2014 and 2013. These grants are described below.

2014 Grant.  On March 26, 2014, we granted 152,000 shares of unrestricted stock to directors, officers and employees. The shares are to be issued in two equal installments shortly after June 30, 2014 and December 31, 2014, provided each grantee is serving as a director, officer or employee on those dates. The total stock-based compensation expense related to this grant is $876,000, of which $287,000 and $589,000 were charged to expense in the three and nine months ended September 30, 2014, respectively. We anticipate the remaining $287,000 will be charged to expense in the fourth quarter of 2014.

We issued shares related to the first installment of this grant as follows: 58,769 net shares of common stock were issued in early July 2014 after employees surrendered 17,231 shares for which we paid $113,000 of withholding taxes on their behalf.

8

2013 Grant.  In April 2013, we granted 130,000 shares of unrestricted stock to directors, officers and employees. The shares were issued in two equal installments shortly after June 30, 2013 and December 31, 2013. We expensed the entire $623,000 stock-based compensation expense related to this grant in the second, third and fourth quarters of 2013. We issued shares of common stock related to this grant as follows: i) 51,374 net shares of common stock were issued in early July 2013 after employees surrendered 13,626 shares for which we paid $71,000 of withholding taxes on their behalf; and ii) 49,936 net shares of common stock were issued in early January 2014 after employees surrendered 15,064 shares for which we paid $92,000 of withholding taxes on their behalf.

F) Business Segments. We organize ourselves into a single segment that reports to the chief operating decision makers.

We conduct our operations in the United States and sell our products and services to domestic and international customers.  Revenues were generated from the following geographic regions for the three and nine months ended September 30, 2014 and 2013 (in thousands):

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2014		2013		2014		2013
United States	$	4,154	$	2,529	$	14,945	$	9,323
Saudi Arabia		39		524		117		613
Rest of World		1,834		1,261		4,349		3,784
	$	6,027	$	4,314	$	19,411	$	13,720

Revenue by product group for the three and nine months ended September 30, 2014 and 2013 was (in thousands):

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2014		2013		2014		2013
Biometrics	$	5,510	$	3,803	$	17,720	$	11,997
Imaging		369		341		1,065		986
DSL royalties		148		170		626		737
	$	6,027	$	4,314	$	19,411	$	13,720

G) Recent Accounting Pronouncements.  In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606). The ASU is the result of a joint project by the FASB and the International Accounting Standards Board (“IASB”) to clarify the principles for recognizing revenue and to develop a common revenue standard for GAAP and International Financial Reporting Standards (“IFRS”) that would: remove inconsistencies and weaknesses, provide a more robust framework for addressing revenue issues, improve comparability of revenue recognition practices across entities, jurisdictions, industries, and capital markets, improve disclosure requirements and resulting financial statements, and simplify the presentation of financial statements. The core principle of the new guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The ASU is effective for annual reporting periods beginning after December 15, 2016.  Early adoption is not permitted. We are currently evaluating the effect that the updated standard will have on our consolidated financial statements and related disclosures.

With the exception of the new revenue standard discussed above, there have been no other recently issued accounting pronouncements that are of significance or potential significance to us that we have not adopted as of September 30, 2014.

9

H) Income Taxes.  Income tax expense was $1.6 million and $0.4 million for the three months ended September 30, 2014 and 2013, respectively. Income tax expense was $2.6 million and $1.6 million for the nine months ended September 30, 2014 and 2013, respectively. Income tax expense in the three and nine month periods of 2014 and 2013 was based on the U.S. statutory rate of 34%, increased by state income taxes.

In the nine month period ended September 30, 2014, we utilized deferred tax assets to reduce our tax liability payable to the government.  A portion of the deferred tax assets we used comprised cumulative deductions for stock options in excess of book expense. Under income tax accounting rules, that portion of tax benefits attributable to such deductions must be recorded as an adjustment to equity versus a reduction of income tax expense. The tax benefits from such stock-based awards were $1.5 million in the nine month period ended September 30, 2014. These tax benefits were recorded as an equity adjustment to additional paid-in capital.

As of September 30, 2014, we had a total of $0.9 million of deferred tax assets for which we had recorded no valuation allowance.  We will continue to assess the level of valuation allowance in future periods.  Should evidence regarding the realizability of tax assets change at a future point in time, the valuation allowance will be adjusted accordingly.

In addition to deferred tax assets carried on our balance sheet, we also had net federal and state research and development credit carryforwards available at December 31, 2013 of $4.9 million and $0.7 million. These credits were not recorded as tax assets as they relate to excess stock compensation deductions that may not be recorded as tax assets under generally accepted accounting principles until the amounts have been utilized to reduce our tax liability. To the extent that these assets are used to reduce future taxes, the benefit will be recorded as a reduction to additional paid-in capital. The aforementioned $1.5 equity adjustment to additional paid-in capital in the nine month period ended September 30, 2014 was related to these deferred tax assets.

In the third quarter of 2014, the Internal Revenue Service commenced an examination of our tax return for the year ended December 31, 2012.

I) Discontinued Operations.  In 2013, we shut down our DSL service assurance software product line, which was previously a component of our DSL Service Assurance Segment. We completed the shutdown in the fourth quarter of 2013 and no longer have any significant continuing involvement with, or cash flows from, this product line. The results of our DSL service assurance software product line have been included in discontinued operations in the consolidated statements of income and comprehensive income. The loss from discontinued operations attributable to the DSL service assurance software product line was (in thousands):

	Three Months Ended September 30,					Nine Months Ended September 30,
	2014		2013			2014		2013
Revenue	$	-	$	156		$	-	$	1,217
Expenses		-		3,355			-		4,866
Loss before income taxes		-		(3,199	)		-		(3,649	)
Income tax benefit		-		1,256			-		1,433
Loss from discontinued operations	$	-	$	(1,943	)	$	-	$	(2,216	)

The consolidated statements of income and comprehensive income for the three and nine months ended September 30, 2013 have been reclassified to reflect the effect of discontinued operations as set forth above.

10

J) Equity

Accumulated Deficit. The changes in accumulated deficit for the nine months ended September 30, 2014 were as follows (in thousands):

Balance as of December 31, 2013	($	16,244	)
Net income		4,344
Dividends paid		(39,905	)
Balance as of September 30, 2014	($	51,805	)

Dividends.  On June 26, 2014, our board of directors declared a special cash dividend of $1.75 per share. The dividend was paid on July 24, 2014 to shareholders of record as of July 10, 2014.  The total dividend payment was $39.9 million.

Accumulated Other Comprehensive Loss. The components of accumulated other comprehensive loss and activity were as follows (in thousands):

	December 31,			Increase/			Reclassification				September 30,
	2013			Decrease			Adjustments				2014
Unrealized losses on available for sale securities	($	206	)	$	26		$	59			($	121	)
Unrealized gains on available for sale securities		-			13			-				13
Net unrealized gains (losses) on available for sale securities		(206	)		39			59		(a)		(108	)
Income tax benefit (expense) on other comprehensive loss		81			(24	)		(20	)			37
Total accumulated other comprehensive loss, net of taxes	($	125	)	$	15		$	39			($	71	)

(a)   – Classified in other expense.

K) Patent related income.  Patent related income in 2014 and 2013 consists of the following:

Three and nine months ended September 30, 2014.  On July 21, 2014, we entered into an agreement to sell a portion of our patent portfolio pertaining to DSL diagnostic technology for $2.6 million to an unrelated third party. The proceeds from the sale were reduced by $0.5 million of transaction costs, which consisted primarily of fees from the law firm that assisted us in the sale.  The transaction closed on August 1, 2014 and a gain of $2.1 million was included in our financial results for the three and nine months ended September 30, 2014.

The DSL diagnostic technology in the patents we sold in August 2014 was related to our DSL Service Assurance business that we shut down in 2012 and 2013 and reported in discontinued operations in those periods. We do not consider our patent related activities to be a component of the operating business from which the underlying technology was derived, but rather as a component of corporate general and administrative expenses.  Accordingly the gain on the sale of these patents was reported in income from continuing operations pursuant to ASC 360, Impairment or Disposal of Long-Lived Assets, and Rule 5-03 of Regulation S-X.

Nine months ended September 30, 2013. In the nine months ended September 30, 2013, we recorded $0.8 million of income from a patent arrangement. We entered into an arrangement with an unaffiliated third party in 2010 under which we assigned certain patents in return for royalties on proceeds from patent monetization efforts by the third party.  Such third party has engaged in various patent monetization activities, including enforcement, litigation and licensing.

We continue to have a contractual relationship with this third party. However, we are unable to predict how much more income we might receive from this arrangement, if any, because:

i)   The claims in one of the patents we assigned were rejected by the United States Patent Office (“USPTO”) in May 2013. The USPTO’s Patent Trial & Appeal Board (“PTAB”) affirmed the USPTO decision in June 2014.  The PTAB decision is currently under appeal to the Federal Circuit, and

ii)   Notwithstanding the outcome in the Federal Circuit, we do not know whether any patent monetization efforts by the third party will be successful.

11

ITEM 2:

Management’s Discussion and Analysis of

Financial Condition and Results of Operations

Cautionary Statement for Purposes of the “Safe Harbor” Provisions of the Private Securities Litigation Reform Act of 1995

Some of the information in this Form 10-Q contains forward-looking statements that involve substantial risks and uncertainties.  You can identify these statements by forward-looking words such as “may,” “will,” “expect,” “anticipate,” “believe,” “estimate,” “continue” and similar words.  You should read statements that contain these words carefully because they: (1) discuss our future expectations; (2) contain projections of our future operating results or financial condition; or (3) state other “forward-looking” information.  However, we may not be able to predict future events accurately.  The risk factors listed in our Annual Report on Form 10-K for the year ended December 31, 2013, as well as any cautionary language in this Form 10-Q, provide examples of risks, uncertainties and events that may cause our actual results to differ materially from the expectations we describe in our forward-looking statements.  You should be aware that the occurrence of any of the events described in these risk factors and elsewhere in this Form 10-Q could materially and adversely affect our business.

Summary of Operations

Continuing Operations. We are primarily engaged in the development and sale of biometrics products and services.  Our biometrics products are used in government and commercial biometrics systems, which are capable of determining or verifying an individual’s identity.  The principal applications of biometrics systems include border control, law enforcement, national defense, secure credentialing, access control and background checks. We sell our software and services to systems integrators and OEMs, as well as directly to government customers.  We also derive a minor portion of our revenue from the sale of imaging software to OEMs that incorporate that software into medical imaging products.

Discontinued Operations. In 2013, we shut down our DSL service assurance software product line, which was previously a component of our DSL Service Assurance Segment. The results of the DSL Service Assurance Segment have been reported as discontinued operations as we no longer have any significant continuing involvement with, or cash flows from, this segment.

Summary of Financial Results

Net income from continuing operations for the three months ended September 30, 2014 was $2.6 million, or $0.11 per diluted share, which compares to net income from continuing operations of $0.8 million, or $0.04 per diluted share, for the three months ended September 30, 2013.  Higher net income from continuing operations in the current three month period was primarily due to: i) a $1.0 million increase in operating income from our biometrics business operations; and ii) a $2.1 million increase in patent related income. The $1.0 million increase in operating income from biometrics was driven by higher software license and service revenue, which was partially offset by higher operating expenses.

Net income from continuing operations for the nine months ended September 30, 2014 was $4.3 million, or $0.19 per diluted share, which compares to net income from continuing operations of $3.2 million, or $0.14 per diluted share, for the nine months ended September 30, 2013.  Higher net income from continuing operations in the current nine month period was primarily due to: i) a $0.9 million increase in operating income from our biometrics business operations; and ii) a $1.3 million increase in patent related income.  The $0.9 million increase in operating income from biometrics was driven by higher hardware and service revenue, which was partially offset by higher operating expenses.

12

Results of Operations

Software licenses.Software licenses consist of revenue from the sale of biometrics and imaging software products. Sales of software products depend on our ability to win proposals to supply software for biometrics systems projects either directly to government customers or indirectly through channel partners.

Software license revenue increased 36% from $2.3 million in the three months ended September 30, 2013 to $3.1 million in the same three month period in 2014.  As a percentage of total revenue, software license revenue decreased from 53% in the third quarter of 2013 to 51% in the current year quarter. The dollar increase in software license revenue was primarily due to a large sale to a U.S. government agency.  We also began to derive revenue from some of our new products this quarter.

Software license revenue decreased 1% from $6.9 million in the nine months ended September 30, 2013 to $6.8 million in the same nine month period in 2014.  As a percentage of total revenue, software license revenue decreased from 50% in the first nine months of 2013 to 35% in the corresponding period of 2014. The slight dollar decrease in software license revenue was primarily due to a large license sale to a U.S. government agency in the first quarter of 2013, which was mostly offset by a large license sale to a U.S. government agency in the third quarter of 2014 as well as higher revenue from other 2014 biometrics projects.

Software maintenance.  Software maintenance consists of revenue from the sale of software maintenance contracts. Software maintenance contracts entitle customers to receive software support and software updates, if and when they become available, during the term of the contract.

Software maintenance revenue increased 16% from $0.9 million in the three months ended September 30, 2013 to $1.1 million in the same three month period in 2014. As a percentage of total revenue, software maintenance revenue decreased from 22% in the third quarter of 2013 to 18% in the current year quarter.

Software maintenance revenue increased 13% from $2.9 million in the nine months ended September 30, 2013 to $3.3 million in the same nine month period in 2014. As a percentage of total revenue, software maintenance revenue decreased from 21% in the first nine months of 2013 to 17% in the corresponding period of 2014.

For the three and nine month periods ended September 30, 2014, the dollar increase in software maintenance revenue was primarily due to a base of maintenance revenue from contract renewals from prior periods that grows as we sell maintenance contracts with new licenses in current periods.

Services. Services consist of fees we charge to perform software development, integration, installation, and customization services. Similar to software license revenue, services revenue depends on our ability to win biometrics systems projects either directly with government customers or in conjunction with channel partners.  Services revenue will fluctuate when we commence new projects and/or when we complete projects that were started in previous periods.

Services increased 68% from $0.9 million in the three months ended September 30, 2013 to $1.6 million in the same three month period in 2014. As a percentage of total revenue, services increased from 22% in the third quarter of 2013 to 26% in the current year quarter.

Services increased 89% from $2.1 million in the nine months ended September 30, 2013 to $3.9 million in the same nine month period in 2014. As a percentage of total revenue, services increased from 15% in the first nine months of 2013 to 20% in the corresponding period of 2014.

For the three and nine month periods ended September 30, 2014, the dollar increase in services was primarily due to a significant project with a U.S. government customer that commenced in the third quarter of 2013 and continued into the current quarter.

13

Hardware sales. Hardware sales consist of sales of biometrics equipment to a single U.S. government customer for whom we developed biometrics software.  Hardware products sold to this customer integrate hardware purchased from third parties with software from other third parties as well as software from Aware. We evaluated the classification of gross versus net revenue recognition and determined gross recognition was appropriate.

Hardware sales increased from $0 in the three months ended September 30, 2013 to $0.1 million in the same three month period in 2014.  As a percentage of total revenue, hardware sales increased from 0% in the third quarter of 2013 to 2% in the current year quarter.

Hardware sales increased 326% from $1.1 million in the nine months ended September 30, 2013 to $4.8 million in the same nine month period in 2014.  As a percentage of total revenue, hardware sales increased from 8% in the first nine months of 2013 to 25% in the corresponding period of 2014.

For the three and nine month periods ended September 30, 2014, the dollar increase in hardware sales was due to an increase in units ordered by our U.S. government hardware customer.

We are unable to predict future hardware sales with any degree of certainty because: i) our contract with the government provides pricing, but does not obligate it to purchase any products until it provides us with purchase orders; and ii) forecasting our customer’s demand is difficult.

Royalties. Royalties consist primarily of royalty payments we receive under DSL silicon contracts with two customers that incorporate our silicon intellectual property (“IP”) in their DSL chipsets.  We sold our DSL IP business in 2009, but we continue to receive royalty payments from these customers.  Royalties are reported in continuing operations in accordance with ASC 205, Reporting Discontinued Operations, because we have continuing ongoing cash flows from this business.

Royalties decreased 13% from $170,000 in the three months ended September 30, 2013 to $148,000 in the same three month period in 2014. As a percentage of total revenue, royalties decreased from 4% in the third quarter of 2013 to 2% in the current year quarter.

Royalties decreased 15% from $737,000 in the nine months ended September 30, 2013 to $626,000 in the same nine month period in 2014. As a percentage of total revenue, royalties decreased from 5% in the first nine months of 2013 to 3% in the corresponding period of 2014.

We believe it is likely that royalties will decline in future quarters.

Cost of hardware sales.  Cost of hardware sales consists primarily of the cost of third party equipment and software included in hardware shipments.

Cost of hardware sales increased from $0 in the three months ended September 30, 2013 to $90,000 in the same three month period in 2014.  Cost of hardware sales as a percentage of hardware sales was 68% in the current year quarter, which means that product gross margins were 32%.

Cost of hardware sales increased 318% from $0.8 million in the nine months ended September 30, 2013 to $3.4 million in the same nine month period in 2014.  Cost of hardware sales as a percentage of hardware sales decreased from 72% in the first nine months of 2013 to 71% in the corresponding period in 2014, which means that product gross margins increased from 28% to 29%.

For the three and nine month periods ended September 30, 2014, the dollar increase in cost of hardware sales was due to higher unit shipments of hardware products in the current year periods compared to the prior year periods.

Cost of Services.  Cost of services consists of engineering costs to perform customer services projects.  Such costs primarily include: i) engineering salaries, stock-based compensation, fringe benefits, and facilities; and ii) engineering consultants and contractors.

14

Cost of services increased 25% from $494,000 in the three months ended September 30, 2013 to $615,000 in the same three month period in 2014. Cost of services as a percentage of services decreased from 52% in the third quarter of 2013 to 39% in the current quarter, which means that gross margins on services increased from 48% to 61%.

Cost of services increased 64% from $1.0 million in the nine months ended September 30, 2013 to $1.7 million in the same nine month period in 2014. Cost of services as a percentage of services decreased from 50% in the first nine months of 2013 to 43% in the corresponding period in 2014, which means that gross margins on services increased from 50% to 57%.

For the three and nine month periods ended September 30, 2014, the dollar increase in cost of services was attributable to an increase in services revenue.  For the three month period ended September 30, 2014, services revenue increased 68% and related cost of services increased 25%.  For the nine month period ended September 30, 2014, services revenue increased 89% and related cost of services increased 64%.

Research and development expense.  Research and development expense consists of costs for: i) engineering personnel, including salaries, stock-based compensation, fringe benefits, and facilities; ii) engineering consultants and contractors, and iii) other engineering expenses such as supplies, equipment depreciation, dues and memberships and travel.  Engineering costs incurred to develop our technology and products are classified as research and development expense. As described in the cost of services section, engineering costs incurred to provide engineering services for customer projects are classified as cost of services, and are not included in research and development expense.

The classification of total engineering costs to research and development expense and cost of services was (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2014		2013		2014		2013
Research and development expense	$	1,381	$	1,043	$	4,060	$	3,042
Cost of services		615		494		1,696		1,035
Total engineering costs	$	1,996	$	1,537	$	5,756	$	4,077

Research and development expense increased 32% from $1.0 million in the three months ended September 30, 2013 to $1.4 million in the same three month period in 2014.  As a percentage of total revenue, research and development expense decreased from 24% in the third quarter of 2013 to 23% in the corresponding period of 2014.

Research and development expense increased 33% from $3.0 million in the nine months ended September 30, 2013 to $4.1 million in the same nine month period in 2014.  As a percentage of total revenue, research and development expense decreased from 22% in the first nine months of 2013 to 21% in the corresponding period of 2014.

As the table immediately above indicates, total engineering costs in the three and nine months periods ended September 30, 2014 increased by $0.5 million and $1.7 million compared to the corresponding three and nine month periods in 2013. The spending increase was primarily due to the hiring of engineering employees and contractors in the second half of 2013 and in the first half of 2014.  Our engineering headcount, not including contractors, grew from 30 employees as of June 30, 2013 to 46 employees as of September 30, 2014.  The expansion of our engineering organization was designed to provide the resources we required to: i) pursue new product development initiatives; and ii) staff customer engineering services projects.

As we described in the strategy section of our Form 10-K for the year ended December 31, 2013, we intend to introduce new products that will allow us to sell more software into biometrics systems projects in order to grow our revenue.  Our preference is to develop such products internally, however to the extent we are unable to do that, we may purchase or license technologies from third parties.  The engineering spending increase in the three and nine month periods ended September 30, 2014 is a reflection of that strategy.  We anticipate that we will continue to focus our future research and development activities on enhancing our existing products and developing new products.

15

Selling and marketing expense. Selling and marketing expense primarily consists of costs for: i) sales and marketing personnel, including salaries, sales commissions, stock-based compensation, fringe benefits, travel, and facilities; and ii) advertising and promotion expenses.

Sales and marketing expense increased 19% from $0.8 million in the three months ended September 30, 2013 to $1.0 million in the same three month period of 2014.  As a percentage of total revenue, sales and marketing expense decreased from 19% in the third quarter of 2013 to 16% in the corresponding period of 2014.

Sales and marketing expense increased 14% from $2.5 million in the nine months ended September 30, 2013 to $2.8 million in the same nine month period of 2014.  As a percentage of total revenue, sales and marketing expense decreased from 18% in the first nine months of 2013 to 14% in the corresponding period of 2014.

For the three and nine month periods ended September 30, 2014, the dollar increase in selling and marketing expense was primarily due to higher sales commissions on higher revenue and the addition of one sales and marketing employee in early 2014.

General and administrative expense.  General and administrative expense consists primarily of costs for: i) officers, directors and administrative personnel, including salaries, bonuses, director compensation, stock-based compensation, fringe benefits, and facilities; ii) professional fees, including legal and audit fees; iii) public company expenses; and iv) other administrative expenses, such as insurance costs and bad debt provisions.

General and administrative expense increased 2% from $922,000 in the three months ended September 30, 2013 to $940,000 in the same three month period in 2014.  As a percentage of total revenue, general and administrative expense decreased from 21% in the third quarter of 2013 to 16% in the current year quarter.The increase in general and administrative expense in the third quarter of 2014 was primarily due to an increase in stock-based compensation which was partially offset by lower patent filing expenses.

General and administrative expense increased 5% from $2.6 million in the nine months ended September 30, 2013 to $2.7 million in the same nine month period in 2014.  As a percentage of total revenue, general and administrative expense decreased from 19% in the first nine months of 2013 to 14% in the corresponding period in 2014. The increase in general and administrative expense in the first nine months of 2014 was primarily due to an increase in stock-based compensation.

Patent related income.  Patent related income in 2014 and 2013 consists of the following:

Three and nine months ended September 30, 2014.  On July 21, 2014, we entered into an agreement to sell a portion of our patent portfolio pertaining to DSL diagnostic technology for $2.6 million to an unrelated third party. The proceeds from the sale were reduced by $0.5 million of transaction costs, which consisted primarily of fees from the law firm that assisted us in the sale.  The transaction closed on August 1, 2014 and a gain of $2.1 million was included in our financial results for the three and nine months ended September 30, 2014.

The DSL diagnostic technology in the patents we sold in August 2014 was related to our DSL Service Assurance business that we shut down in 2012 and 2013 and reported in discontinued operations in those periods. We do not consider our patent related activities to be a component of the operating business from which the underlying technology was derived, but rather as a component of corporate general and administrative expenses.  Accordingly the gain on the sale of these patents was reported in income from continuing operations pursuant to ASC 360, Impairment or Disposal of Long-Lived Assets, and Rule 5-03 of Regulation S-X.

16

Nine months ended September 30, 2013. In the nine months ended September 30, 2013, we recorded $0.8 million of income from a patent arrangement. We entered into an arrangement with an unaffiliated third party in 2010 under which we assigned certain patents in return for royalties on proceeds from patent monetization efforts by the third party.  Such third party has engaged in various patent monetization activities, including enforcement, litigation and licensing.

We continue to have a contractual relationship with this third party. However, we are unable to predict how much more income we might receive from this arrangement, if any, because:

i)   The claims in one of the patents we assigned were rejected by the United States Patent Office (“USPTO”) in May 2013. The USPTO’s Patent Trial & Appeal Board (“PTAB”) affirmed the USPTO decision in June 2014.  The PTAB decision is currently under appeal to the Federal Circuit, and

ii)   Notwithstanding the outcome in the Federal Circuit, we do not know whether any patent monetization efforts by the third party will be successful.

Other expense.  We recorded $59,000 of other expense in the nine months ended September 30, 2014.  This amount represented realized losses on sales and calls of high yield bond investments.

Interest income.  Interest income decreased 46% from $80,000 in three months ended September 30, 2013 to $43,000 in the same three month period in 2014.

Interest income decreased 24% from $239,000 in the nine months ended September 30, 2013 to $182,000 in the same nine month period in 2014.

For the three and nine month periods, the dollar decrease in interest income was primarily due to two factors: i) lower levels of high yield bond investments in 2014 as compared to 2013; and ii) lower cash balances as a result of a $39.9 million dividend payment in July 2014.

Income taxes.   Income tax expense was $1.6 million and $0.4 million for the three months ended September 30, 2014 and 2013, respectively. Income tax expense was $2.6 million and $1.6 million for the nine months ended September 30, 2014 and 2013, respectively. Income tax expense in the three and nine month periods of 2014 and 2013 was based on the U.S. statutory rate of 34%, increased by state income taxes.

In the nine month period ended September 30, 2014, we utilized deferred tax assets to reduce our tax liability payable to the government.  A portion of the deferred tax assets we used comprised cumulative deductions for stock options in excess of book expense. Under income tax accounting rules, that portion of tax benefits attributable to such deductions must be recorded as an adjustment to equity versus a reduction of income tax expense. The tax benefits from such stock-based awards were $1.5 million in the nine month period ended September 30, 2014. These tax benefits were recorded as an equity adjustment to additional paid-in capital.

As of September 30, 2014, we had a total of $0.9 million of deferred tax assets for which we had recorded no valuation allowance.  We will continue to assess the level of valuation allowance in future periods.  Should evidence regarding the realizability of tax assets change at a future point in time, the valuation allowance will be adjusted accordingly.

In addition to deferred tax assets carried on our balance sheet, we also had net federal and state research and development credit carryforwards available at December 31, 2013 of $4.9 million and $0.7 million. These credits were not recorded as tax assets as they relate to excess stock compensation deductions that may not be recorded as tax assets under generally accepted accounting principles until the amounts have been utilized to reduce our tax liability. To the extent that these assets are used to reduce future taxes, the benefit will be recorded as a reduction to additional paid-in capital. The aforementioned $1.5 equity adjustment to additional paid-in capital in the nine month period ended September 30, 2014 was related to these deferred tax assets.

In the third quarter of 2014, the Internal Revenue Service commenced an examination of our tax return for the year ended December 31, 2012.

17

Loss from discontinued operations.Loss from discontinued operations reflects operating results from our DSL service assurance software product line that we shut down during 2013. The loss from such discontinued operations was (in thousands):

	Three Months Ended September 30,					Nine Months Ended September 30,
	2014		2013			2014		2013
Revenue	$	-	$	156		$	-	$	1,217
Expenses		-		3,355			-		4,866
Loss before income taxes		-		(3,199	)		-		(3,649	)
Income tax benefit		-		1,256			-		1,433
Loss from discontinued operations	$	-	($	1,943	)	$	-	($	2,216	)

Liquidity and Capital Resources

At September 30, 2014, we had cash and cash equivalents of $43.5 million, which represented a decrease of $29.2 million from December 31, 2013. The decrease in cash was primarily due to $38.2 million of cash used by financing activities, which was partially offset by $5.6 million of cash provided by operations and $3.4 million of cash provided by investing activities.

Cash provided by investing activities of $3.4 million consisted of $1.4 million from sales of investments and $2.1 million of net proceeds from the sale of patent assets. Cash provided by these two activities was partially offset by $0.1 million of capital spending.

Cash used by financing activities of $38.2 million was primarily the result of a $39.9 million special cash dividend paid on July 24, 2014 and $0.2 million of cash used to pay income taxes for employees who surrendered shares in connection with stock grants. Cash used by these two activities was partially offset by: i) $1.5 million of excess tax benefits from stock-based compensation, and ii) $0.5 million of proceeds from the exercise of stock options.

While we cannot assure you that we will not require additional financing, or that such financing will be available to us, we believe that our cash and cash equivalents will be sufficient to fund our operations for at least the next twelve months.

Recent Accounting Pronouncements

See Note G to our Consolidated Financial Statements in Item 1.

18

ITEM 3:

Quantitative and Qualitative Disclosures about Market Risk

Our exposure to market risk relates primarily to our investment portfolio, and the effect that changes in interest rates would have on that portfolio. Our investment portfolio at September 30, 2014 consisted of two elements:

1.   Cash and cash equivalents. As of September 30, 2014, our cash and cash equivalents of $43.5 million were primarily invested in money market funds. The money market funds were invested in high quality, short term financial instruments. Due to the nature, short duration, and professional management of these funds, we do not expect that a general increase in interest rates would result in any material loss.

2.   Investments. As of September 30, 2014, our investments of $1.4 million were invested in high yield bonds withthree corporate debt issuers, which mature in 2017 and 2018.  While we are exposed to default risk, the high current yield of these bonds largely mitigates interest rate risk. Therefore, due to the high current yield and the three to four year life of these instruments, we do not believe that a general increase in interest rates would result in any material loss.

We do not use derivative financial instruments for speculative or trading purposes.

ITEM 4:

Controls and Procedures

Our management, including our co-chief executive officers and chief financial officer, has evaluated our disclosure controls and procedures as of the end of the quarterly period covered by this Form 10-Q and has concluded that our disclosure controls and procedures are effective.  They also concluded that there were no changes in our internal control over financial reporting that occurred during the quarterly period covered by this Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

19

PART II.  OTHER INFORMATION

ITEM 1:

Legal Proceedings

From time to time we are involved in litigation incidental to the conduct of our business.  We are not party to any lawsuit or proceeding that, in our opinion, is likely to seriously harm our business.

ITEM 1A:

Risk Factors

The risks described in Item 1A, Risk Factors, in our Annual Report on Form 10-K for the year ended December 31, 2013, could materially and adversely affect our business, financial condition and results of operations. The risk factors discussed in that Form 10-K do not identify all risks that we face because our business operations could also be affected by additional factors that are not presently known to us or that we currently consider to be immaterial to our operations. No material change in the risk factors discussed in that Form 10-K has occurred.

ITEM 4:

Mine Safety Disclosures

Not applicable.

20

ITEM 6:

Exhibits

(a)  Exhibits

Exhibit 31.1 Certification of co-Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Exhibit 31.2 Certification of co-Chief Executive Officer and Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Exhibit 32.1 Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

Exhibit 101*  The following financial statements from Aware, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2014, formatted in XBRL (eXtensible Business Reporting Language), as follows:  (i) Consolidated Balance Sheets as of September 30, 2014 and December 31, 2013, (ii) Consolidated Statements of Income and Comprehensive Income for the Three and Nine Months Ended September 30, 2014 and September 30, 2013, (iii) Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2014 and September 30, 2013, and (iv) Notes to Consolidated Financial Statements.

*  Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files in Exhibit 101 hereto shall not be deemed filed for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, or Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability under those sections.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	AWARE, INC.
Date: October 24, 2014	By:	/s/ Kevin T. Russell
		Kevin T. Russell
		co-Chief Executive Officer & co-President
		General Counsel

Date: October 24, 2014	By:	/s/ Richard P. Moberg
		Richard P. Moberg
		co-Chief Executive Officer & co-President
		Chief Financial Officer (Principal Financial and Accounting Officer)

21

EX-31.1

Exhibit 31.1

CERTIFICATION OF co-CHIEF EXECUTIVE OFFICER

I, Kevin T. Russell, co-Chief Executive Officer of Aware, Inc., certify that:

1. I have reviewed this quarterly report on Form 10-Q of Aware, Inc.;

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3. Based on my  knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this quarterly report based on such evaluation; and

d) disclosed in this quarterly report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:  October 24, 2014	/s/ Kevin T. Russell
	Kevin T. Russell
	co-Chief Executive Officer & co-President

EX-31.2

Exhibit 31.2

CERTIFICATION OF co-CHIEF EXECUTIVE OFFICER and CHIEF FINANCIAL OFFICER

I, Richard P. Moberg, co-Chief Executive Officer and Chief Financial Officer of Aware, Inc., certify that:

1. I have reviewed this quarterly report on Form 10-Q of Aware, Inc.;

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this quarterly report based on such evaluation; and

d) disclosed in this quarterly report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: October 24, 2014	/s/ Richard P. Moberg
	Richard P. Moberg
	co-Chief Executive Officer & co-President
	Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C.  SECTION 1350)

In connection with the Quarterly Report on Form 10-Q of Aware, Inc. (the “Company”) for the quarter ended September 30, 2014, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned Chief Executive Officer and Chief Financial Officer of the Company, certifies, to the best knowledge and belief of the signatory, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)   The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)   The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/   Kevin T. Russell	/s/   Richard P. Moberg
co-Chief Executive Officer & co-President	co-Chief Executive Officer & co-President
	Chief Financial Officer
Date:  October 24, 2014	Date: October 24, 2014

The certification set forth above is being furnished as an exhibit solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and is not being filed as part of the Form 10-Q or as a separate disclosure document of the Company or the certifying officers.

XML

Income Taxes (Detail Textuals) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013 Federal Research and development credit carryforwards	Dec. 31, 2013 State Research and development credit carryforwards
Operating Loss Carryforwards [Line Items]
Income tax expense	$ 1,599,000	$ 355,000	$ 2,625,000	$ 1,603,000
Income tax U.S. statutory rate	34.00%	34.00%	34.00%	34.00%
Tax benefits from stock-based awards			1,500,000
Deferred tax assets	900,000		900,000
Net federal and state research and development credit carryforwards					4,900,000	700,000
Equity adjustment to additional paid-in capital			$ 1,500,000

XML

Fair Value Measurements (Detail Textuals) (USD $) In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013	Sep. 30, 2013	Dec. 31, 2012
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents, primarily include money market funds	$ 43,507	$ 72,660	$ 75,418	$ 71,074
Fair value on recurring basis | Corporate debt securities | Fair Value Measurement, Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale investments	1,362	2,754
Fair value on recurring basis | Money market funds (included in cash and cash equivalents) | Fair Value Measurement, Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents, primarily include money market funds	$ 34,300	$ 68,600

XML

Equity (Detail Textuals) (USD $) In Millions, except Per Share data, unless otherwise specified	1 Months Ended
	Jun. 26, 2014
Equity [Abstract]
Dividend declared date	Jun. 26, 2014
Cash dividend declared (in dollars per share)	$ 1.75
Dividends payable date	Jul. 24, 2014
Shareholders of record date	Jul. 10, 2014
Dividends payable	$ 39.9

XML

Computation of Earnings per Share

9 Months Ended

Sep. 30, 2014

Earnings Per Share [Abstract]

Computation of Earnings per Share

D) Computation of Earnings per Share. Basic earnings per share is computed by dividing net income or loss by the weighted average number of common shares outstanding.  Diluted earnings per share is computed by dividing net income or loss by the weighted average number of common shares outstanding plus additional common shares that would have been outstanding if dilutive potential common shares had been issued.  For the purposes of this calculation, stock options are considered common stock equivalents in periods in which they have a dilutive effect.  Stock options that are anti-dilutive are excluded from the calculation.

Net income per share is calculated as follows (in thousands, except per share data):

	Three Months Ended September 30,					Nine Months Ended September 30,
	2014		2013			2014		2013
Net income:
Income from continuing operations	$	2,599	$	790		$	4,344	$	3,227
Loss from discontinued operations		-		(1,943	)		-		(2,216	)
Net income (loss)	$	2,599	$	(1,153	)	$	4,344	$	1,011
Shares outstanding:
Weighted-average common shares outstanding		22,804		22,571			22,687		22,533
Additional dilutive common stock equivalents		89		-			94		90
Diluted shares outstanding		22,893		22,571			22,781		22,623
Basic net income (loss) per share:
Basic net income per share from continuing operations	$	0.11	$	0.04		$	0.19	$	0.14
Basic net loss per share from discontinued operations		0.00		(0.09	)		0.00		(0.10	)
Basic net income (loss) per share	$	0.11	$	(0.05	)	$	0.19	$	0.04
Diluted net income (loss) per share:
Diluted net income per share from continuing operations	$	0.11	$	0.04		$	0.19	$	0.14
Diluted net loss per share from discontinued operations		0.00		(0.09	)		0.00		(0.10	)
Diluted net income (loss) per share	$	0.11	$	(0.05	)	$	0.19	$	0.04

For the three month period ended September 30, 2013, common stock equivalents of 111,349 were not included in the per share calculation for diluted EPS, because we had a net loss and the effect of their inclusion would be anti-dilutive.

For the three month periods ended September 30, 2014 and 2013, options to purchase 40,834 and 825,338 shares of common stock, respectively, were outstanding, but were not included in the computation of diluted EPS because the options’ exercise prices were greater than the average market price of the common stock and thus would be anti-dilutive.

For the nine month periods ended September 30, 2014 and 2013, options to purchase 40,834 and 825,338 shares of common stock, respectively, were outstanding, but were not included in the computation of diluted EPS because the options’ exercise prices were greater than the average market price of the common stock and thus would be anti-dilutive.

XML

Stock-Based Compensation - Summary of stock-based employee compensation expenses (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation	$ 297	$ 217	$ 619	$ 445
Cost of services
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation	15	12	30	23
Research and development
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation	34	26	71	53
Selling and marketing
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation	6	5	12	10
General and administrative
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation	$ 242	$ 174	$ 506	$ 359

XML

Computation of Earnings per Share (Detail Textuals)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock Share purchase (in shares)	40,834	825,338	40,834	825,338
Other Common Stock Equivalent
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock Share purchase (in shares)	111,349

XML

Stock-Based Compensation (Detail Textuals) (Unrestricted Stock Grants, 2001 Nonqualified Stock Plan, Directors, officers and employees, USD $)	1 Months Ended	3 Months Ended	9 Months Ended	1 Months Ended	3 Months Ended	6 Months Ended	9 Months Ended
	Mar. 26, 2014 2014 Grant	Sep. 30, 2014 2014 Grant	Sep. 30, 2014 2014 Grant	Apr. 30, 2013 2013 Grant	Jun. 30, 2013 2013 Grant	Dec. 31, 2013 2013 Grant	Dec. 31, 2013 2013 Grant
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares granted (in shares)	152,000			130,000
Stock-based compensation expense		$ 287,000	$ 589,000				$ 623,000
Total stock-based compensation expense			876,000
Number of shares issued (in shares)			58,769		51,374	49,936
Number of common stock shares surrendered by employees withholding taxes			17,231		13,626	15,064
Common stock value surrendered by employees withholding taxes			$ 113,000		$ 71,000	$ 92,000

XML

Business Segments - Revenues generated following geographic regions (Details ) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Segment Reporting Information [Line Items]
Revenue:	$ 6,027	$ 4,314	$ 19,411	$ 13,720
Operating Segments | United States
Segment Reporting Information [Line Items]
Revenue:	4,154	2,529	14,945	9,323
Operating Segments | Saudi Arabia
Segment Reporting Information [Line Items]
Revenue:	39	524	117	613
Operating Segments | Rest of World
Segment Reporting Information [Line Items]
Revenue:	$ 1,834	$ 1,261	$ 4,349	$ 3,784

XML

Inventories

9 Months Ended

Sep. 30, 2014

Inventory Disclosure [Abstract]

Inventories

C)   Inventories. Inventories are stated at the lower of cost or net realizable value with cost being determined by the first-in, first-out (“FIFO”) method.  Inventories consisted of the following (in thousands):

	September 30, 2014		December 31, 2013
Raw materials	$	2	$	1,584
Finished goods		-		17
Total	$	2	$	1,601

XML

Business Segments - Summary of revenue by product group (Details 1) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Segment Reporting Information [Line Items]
Revenue:	$ 6,027	$ 4,314	$ 19,411	$ 13,720
Operating Segments | Biometrics
Segment Reporting Information [Line Items]
Revenue:	5,510	3,803	17,720	11,997
Operating Segments | Imaging
Segment Reporting Information [Line Items]
Revenue:	369	341	1,065	986
Operating Segments | DSL royalties
Segment Reporting Information [Line Items]
Revenue:	$ 148	$ 170	$ 626	$ 737

XML

CONSOLIDATED BALANCE SHEETS (unaudited) (USD $) In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Current assets:
Cash and cash equivalents	$ 43,507	$ 72,660
Accounts receivable, net	3,950	4,582
Inventories	2	1,601
Deferred tax assets	214	383
Prepaid expenses and other current assets	435	695
Total current assets	48,108	79,921
Property and equipment, net	5,374	5,582
Investments	1,362	2,754
Long term deferred tax assets	729	762
Other assets	225	310
Total assets	55,798	89,329
Current liabilities:
Accounts payable	179	1,516
Accrued expenses	100	108
Accrued compensation	600	571
Accrued professional	155	118
Accrued income taxes	57
Deferred revenue	2,622	1,848
Total current liabilities	3,713	4,161
Long-term deferred revenue	76	18
Commitments and contingent liabilities
Stockholders' equity:
Preferred stock, $1.00 par value; 1,000,000 shares authorized, none outstanding
Common stock, $.01 par value; 70,000,000 shares authorized; issued and outstanding 22,804,720 as of September 30, 2014 and 22,574,251 as of December 31, 2013	228	226
Additional paid-in capital	103,657	101,293
Accumulated other comprehensive loss	(71)	(125)
Accumulated deficit	(51,805)	(16,244)
Total stockholders' equity	52,009	85,150
Total liabilities and stockholders' equity	$ 55,798	$ 89,329

XML

Basis of Presentation

9 Months Ended

Sep. 30, 2014

Basis Of Accounting [Abstract]

Basis of Presentation

A) Basis of Presentation. The accompanying unaudited consolidated financial statements have been prepared in accordance with the instructions for Form 10-Q and therefore do not include all information and notes necessary for a complete presentation of our financial position, results of operations and cash flows, in conformity with generally accepted accounting principles.  We filed audited financial statements which included all information and notes necessary for such presentation for the three years ended December 31, 2013 in conjunction with our 2013 Annual Report on Form 10-K. This Form 10-Q should be read in conjunction with that Form 10-K.

The accompanying unaudited consolidated balance sheets, statements of income and comprehensive income, and statements of cash flows reflect all adjustments (consisting only of normal recurring items) which are, in the opinion of management, necessary for a fair presentation of financial position at September 30, 2014, and of operations and cash flows for the interim periods ended September 30, 2014 and 2013.

The results of operations for the interim period ended September 30, 2014 are not necessarily indicative of the results to be expected for the year.

XML

Equity - Changes in accumulated deficit (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Equity [Abstract]
Balance as of December 31, 2013			$ (16,244)
Net income	2,599	(1,153)	4,344	1,011
Dividends paid			(39,905)
Balance as of September 30, 2014	$ (51,805)		$ (51,805)

XML

Discontinued Operations (Tables)

9 Months Ended

Sep. 30, 2014

Discontinued Operations and Disposal Groups [Abstract]

Schedule of loss from discontinued operations attributable to the DSL service assurance software product line

	Three Months Ended September 30,					Nine Months Ended  September 30,
	2014		2013			2014		2013
Revenue	$	-	$	156		$	-	$	1,217
Expenses		-		3,355			-		4,866
Loss before income taxes		-		(3,199	)		-		(3,649	)
Income tax benefit		-		1,256			-		1,433
Loss from discontinued operations	$	-	$	(1,943	)	$	-	$	(2,216	)

XML

Equity - Components of accumulated other comprehensive loss and activity (Details 1) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2014
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance Net unrealized gains (losses) on available for sale securities	$ (206)
Beginning balance Income tax benefit (expense) on other comprehensive loss	81
Beginning balance Total accumulated other comprehensive loss, net of taxes	(125)
Increase/Decrease Net unrealized gains (losses) on available for sale securities	39
Increase/Decrease Income tax benefit (expense) on other comprehensive loss	(24)
Increase/Decrease Total accumulated other comprehensive loss, net of taxes	15
Reclassification Adjustments Net unrealized gains (losses) on available for sale securities	59	[1]
Reclassification Adjustments Income tax benefit (expense) on other comprehensive loss	(20)
Reclassification Adjustments Total accumulated other comprehensive loss, net of taxes	39
Ending balance Net unrealized gains (losses) on available for sale securities	(108)
Ending balance Income tax benefit (expense) on other comprehensive loss	37
Ending balance Total accumulated other comprehensive loss, net of taxes	(71)
Unrealized losses on available for sale securities
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance Net unrealized gains (losses) on available for sale securities	(206)
Increase/Decrease Net unrealized gains (losses) on available for sale securities	26
Reclassification Adjustments Net unrealized gains (losses) on available for sale securities	59
Ending balance Net unrealized gains (losses) on available for sale securities	(121)
Unrealized gains on available for sale securities
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance Net unrealized gains (losses) on available for sale securities
Increase/Decrease Net unrealized gains (losses) on available for sale securities	13
Reclassification Adjustments Net unrealized gains (losses) on available for sale securities
Ending balance Net unrealized gains (losses) on available for sale securities	$ 13

[1] Classified in other expense.

XML

Fair Value Measurements - Assets measured at fair value on a recurring basis (Details) (Fair value on recurring basis, USD $) In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Fair Value Measurement, Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	$ 35,651	$ 71,310
Fair Value Measurement, Quoted Prices in Active Markets for Identical Assets (Level 1) | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Corporate debt securities	1,362	2,754
Fair Value Measurement, Quoted Prices in Active Markets for Identical Assets (Level 1) | Money market funds (included in cash and cash equivalents)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market funds (included in cash and cash equivalents)	34,289	68,556
Fair Value Measurement, Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value
Fair Value Measurement, Significant Other Observable Inputs (Level 2) | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Corporate debt securities
Fair Value Measurement, Significant Other Observable Inputs (Level 2) | Money market funds (included in cash and cash equivalents)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market funds (included in cash and cash equivalents)
Fair Value Measurement, Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value
Fair Value Measurement, Significant Unobservable Inputs (Level 3) | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Corporate debt securities
Fair Value Measurement, Significant Unobservable Inputs (Level 3) | Money market funds (included in cash and cash equivalents)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market funds (included in cash and cash equivalents)

XML

Fair Value Measurements

9 Months Ended

Sep. 30, 2014

Fair Value Disclosures [Abstract]

Fair Value Measurements

B) Fair Value Measurements. The Financial Accounting Standards Board (“FASB”) Codification defines fair value, and establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to the unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). The three levels of the fair value hierarchy under the FASB Codification are: i) Level 1 – valuations that are based on quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date; ii) Level 2 – valuations that are based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly; and iii) Level 3 – valuations that require inputs that are both significant to the fair value measurement and unobservable.

Cash and cash equivalents, which primarily include money market mutual funds, were $43.5 million and $72.7 million as of September 30, 2014 and December 31, 2013, respectively. We classified our cash equivalents of $34.3 million and $68.6 million as of September 30, 2014 and December 31, 2013 within Level 1 of the fair value hierarchy because they are valued using quoted market prices.

Our investments, which consist of high yield corporate debt securities, are also classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices. We categorize our investments as available-for-sale securities, and carry them at fair value in our financial statements.  We had $1.4 million and $2.8 million of available-for-sale investments as of September 30, 2014 and December 31, 2013, respectively.

As of September 30, 2014, our assets that are measured at fair value on a recurring basis and whose carrying values approximate their respective fair values include the following (in thousands):

	Fair Value Measurement at September 30, 2014 Using:
	Quoted Prices in Active Markets for Identical Assets		Significant Other Observable Inputs		Significant Unobservable Inputs
	(Level 1)		(Level 2)		(Level 3)
Corporate debt securities	$	1,362	$	-	$	-
Money market funds (included in cash and cash equivalents)		34,289
Total	$	35,651	$	-	$	-

As of December 31, 2013, our assets that are measured at fair value on a recurring basis and whose carrying values approximate their respective fair values include the following (in thousands):

	Fair Value Measurement at December 31, 2013 Using:
	Quoted Prices in Active Markets for Identical Assets		Significant Other Observable Inputs		Significant Unobservable Inputs
	(Level 1)		(Level 2)		(Level 3)
Corporate debt securities	$	2,754	$	-	$	-
Money market funds (included in cash and cash equivalents)		68,556
Total	$	71,310	$	-	$	-

XML

CONSOLIDATED BALANCE SHEETS (unaudited) (Parentheticals) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Statement Of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 1.00	$ 1.00
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares outstanding
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized	70,000,000	70,000,000
Common stock, shares issued	22,804,720	22,574,251
Common stock, shares outstanding	22,804,720	22,574,251

XML

Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2014

Fair Value Disclosures [Abstract]

Schedule of assets measured at fair value on a recurring basis

	Fair Value Measurement at September 30, 2014 Using:
	Quoted Prices in  Active Markets for Identical Assets		Significant Other  Observable Inputs		Significant  Unobservable  Inputs
	(Level 1)		(Level 2)		(Level 3)
Corporate debt securities	$	1,362	$	-	$	-
Money market funds (included in cash and cash equivalents)		34,289
Total	$	35,651	$	-	$	-

	Fair Value Measurement at December 31, 2013 Using:
	Quoted Prices in  Active Markets for Identical Assets		Significant Other  Observable Inputs		Significant Unobservable  Inputs
	(Level 1)		(Level 2)		(Level 3)
Corporate debt securities	$	2,754	$	-	$	-
Money market funds (included in cash and cash equivalents)		68,556
Total	$	71,310	$	-	$	-

XML

Document and Entity Information	9 Months Ended
	Sep. 30, 2014	Oct. 20, 2014
Document and Entity Information [Abstract]
Entity Registrant Name	AWARE INC /MA/
Entity Central Index Key	0001015739
Trading Symbol	awre
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		22,804,720
Document Type	10-Q
Document Period End Date	Sep. 30, 2014
Amendment Flag	false
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	Q3

XML

Inventories (Tables)

9 Months Ended

Sep. 30, 2014

Inventory Disclosure [Abstract]

Schedule of inventories

	September 30, 2014		December 31, 2013
Raw materials	$	2	$	1,584
Finished goods		-		17
Total	$	2	$	1,601

XML

CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (unaudited) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Revenue:
Software licenses	$ 3,077	$ 2,268	$ 6,759	$ 6,860
Software maintenance	1,085	933	3,282	2,914
Services	1,585	943	3,931	2,080
Hardware sales	132		4,813	1,129
Royalties	148	170	626	737
Total revenue	6,027	4,314	19,411	13,720
Costs and expenses:
Cost of hardware sales	90		3,403	813
Cost of services	615	494	1,697	1,035
Research and development	1,381	1,043	4,060	3,042
Selling and marketing	973	817	2,813	2,466
General and administrative	940	922	2,719	2,580
Total costs and expenses	3,999	3,276	14,692	9,936
Patent related income	2,127		2,127	780
Operating income	4,155	1,038	6,846	4,564
Other income (expense)		27	(59)	27
Interest income	43	80	182	239
Income from continuing operations before income taxes	4,198	1,145	6,969	4,830
Provision for income taxes	1,599	355	2,625	1,603
Income from continuing operations	2,599	790	4,344	3,227
Loss from discontinued operations, net of income taxes		(1,943)		(2,216)
Net income (loss)	2,599	(1,153)	4,344	1,011
Basic net income (loss) per share:
Basic net income per share from continuing operations	$ 0.11	$ 0.04	$ 0.19	$ 0.14
Basic net loss share from discontinued operations	$ 0.00	$ (0.09)	$ 0.00	$ (0.10)
Basic net income (loss) per share	$ 0.11	$ (0.05)	$ 0.19	$ 0.04
Diluted net income (loss) per share:
Diluted net income per share from continuing operations	$ 0.11	$ 0.04	$ 0.19	$ 0.14
Diluted net loss per share from discontinued operations	$ 0.00	$ (0.09)	$ 0.00	$ (0.10)
Diluted net income (loss) per share	$ 0.11	$ (0.05)	$ 0.19	$ 0.04
Weighted-average shares - basic	22,804	22,571	22,687	22,533
Weighted-average shares - diluted	22,893	22,571	22,781	22,623
Comprehensive income (loss):
Net income (loss)	2,599	(1,153)	4,344	1,011
Other comprehensive income (net of tax):
Unrealized gains (losses) on available for sale securities	(67)	(26)	54	(6)
Comprehensive income (loss)	$ 2,532	$ (1,179)	$ 4,398	$ 1,005

XML

Recent Accounting Pronouncements

9 Months Ended

Sep. 30, 2014

Accounting Changes and Error Corrections [Abstract]

Recent Accounting Pronouncements

G) Recent Accounting Pronouncements.  In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606). The ASU is the result of a joint project by the FASB and the International Accounting Standards Board (“IASB”) to clarify the principles for recognizing revenue and to develop a common revenue standard for GAAP and International Financial Reporting Standards (“IFRS”) that would: remove inconsistencies and weaknesses, provide a more robust framework for addressing revenue issues, improve comparability of revenue recognition practices across entities, jurisdictions, industries, and capital markets, improve disclosure requirements and resulting financial statements, and simplify the presentation of financial statements. The core principle of the new guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The ASU is effective for annual reporting periods beginning after December 15, 2016.  Early adoption is not permitted. We are currently evaluating the effect that the updated standard will have on our consolidated financial statements and related disclosures.

With the exception of the new revenue standard discussed above, there have been no other recently issued accounting pronouncements that are of significance or potential significance to us that we have not adopted as of September 30, 2014.

XML

Business Segments

9 Months Ended

Sep. 30, 2014

Segment Reporting [Abstract]

Business Segments

F) Business Segments. We organize ourselves into a single segment that reports to the chief operating decision makers.

We conduct our operations in the United States and sell our products and services to domestic and international customers.  Revenues were generated from the following geographic regions for the three and nine months ended September 30, 2014 and 2013 (in thousands):

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2014		2013		2014		2013
United States	$	4,154	$	2,529	$	14,945	$	9,323
Saudi Arabia		39		524		117		613
Rest of World		1,834		1,261		4,349		3,784
	$	6,027	$	4,314	$	19,411	$	13,720

Revenue by product group for the three and nine months ended September 30, 2014 and 2013 was (in thousands):

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2014		2013		2014		2013
Biometrics	$	5,510	$	3,803	$	17,720	$	11,997
Imaging		369		341		1,065		986
DSL royalties		148		170		626		737
	$	6,027	$	4,314	$	19,411	$	13,720

XML

Equity (Tables)

9 Months Ended

Sep. 30, 2014

Equity [Abstract]

Schedule of changes in accumulated deficit

Balance as of December 31, 2013	($	16,244	)
Net income		4,344
Dividends paid		(39,905	)
Balance as of September 30, 2014	($	51,805	)

Schedule of components of accumulated other comprehensive loss and activity

	December 31,			Increase/			Reclassification				September 30,
	2013			Decrease			Adjustments				2014
Unrealized losses on available for sale securities	($	206	)	$	26		$	59			($	121	)
Unrealized gains on available for sale securities		-			13			-				13
Net unrealized gains (losses) on available for sale securities		(206	)		39			59		(a)		(108	)
Income tax benefit (expense) on other comprehensive loss		81			(24	)		(20	)			37
Total accumulated other comprehensive loss, net of taxes	($	125	)	$	15		$	39			($	71	)

(a)   – Classified in other expense.

XML

Computation of Earnings per Share (Tables)

9 Months Ended

Sep. 30, 2014

Earnings Per Share [Abstract]

Schedule of net income per share

	Three Months Ended September 30,					Nine Months Ended September 30,
	2014		2013			2014		2013
Net income:
Income from continuing operations	$	2,599	$	790		$	4,344	$	3,227
Loss from discontinued operations		-		(1,943	)		-		(2,216	)
Net income (loss)	$	2,599	$	(1,153	)	$	4,344	$	1,011
Shares outstanding:
Weighted-average common shares outstanding		22,804		22,571			22,687		22,533
Additional dilutive common stock equivalents		89		-			94		90
Diluted shares outstanding		22,893		22,571			22,781		22,623
Basic net income (loss) per share:
Basic net income per share from continuing operations	$	0.11	$	0.04		$	0.19	$	0.14
Basic net loss per share from discontinued operations		0.00		(0.09	)		0.00		(0.10	)
Basic net income (loss) per share	$	0.11	$	(0.05	)	$	0.19	$	0.04
Diluted net income (loss) per share:
Diluted net income per share from continuing operations	$	0.11	$	0.04		$	0.19	$	0.14
Diluted net loss per share from discontinued operations		0.00		(0.09	)		0.00		(0.10	)
Diluted net income (loss) per share	$	0.11	$	(0.05	)	$	0.19	$	0.04

XML

Equity

9 Months Ended

Sep. 30, 2014

Equity [Abstract]

Equity

J) Equity

Accumulated Deficit. The changes in accumulated deficit for the nine months ended September 30, 2014 were as follows (in thousands):

Balance as of December 31, 2013	($	16,244	)
Net income		4,344
Dividends paid		(39,905	)
Balance as of September 30, 2014	($	51,805	)

Dividends.  On June 26, 2014, our board of directors declared a special cash dividend of $1.75 per share. The dividend was paid on July 24, 2014 to shareholders of record as of July 10, 2014.  The total dividend payment was $39.9 million.

Accumulated Other Comprehensive Loss. The components of accumulated other comprehensive loss and activity were as follows (in thousands):

	December 31,			Increase/			Reclassification				September 30,
	2013			Decrease			Adjustments				2014
Unrealized losses on available for sale securities	($	206	)	$	26		$	59			($	121	)
Unrealized gains on available for sale securities		-			13			-				13
Net unrealized gains (losses) on available for sale securities		(206	)		39			59		(a)		(108	)
Income tax benefit (expense) on other comprehensive loss		81			(24	)		(20	)			37
Total accumulated other comprehensive loss, net of taxes	($	125	)	$	15		$	39			($	71	)

(a)   – Classified in other expense.

XML

Income Taxes

9 Months Ended

Sep. 30, 2014

Income Tax Disclosure [Abstract]

Income Taxes

H) Income Taxes.  Income tax expense was $1.6 million and $0.4 million for the three months ended September 30, 2014 and 2013, respectively. Income tax expense was $2.6 million and $1.6 million for the nine months ended September 30, 2014 and 2013, respectively. Income tax expense in the three and nine month periods of 2014 and 2013 was based on the U.S. statutory rate of 34%, increased by state income taxes.

In the nine month period ended September 30, 2014, we utilized deferred tax assets to reduce our tax liability payable to the government.  A portion of the deferred tax assets we used comprised cumulative deductions for stock options in excess of book expense. Under income tax accounting rules, that portion of tax benefits attributable to such deductions must be recorded as an adjustment to equity versus a reduction of income tax expense. The tax benefits from such stock-based awards were $1.5 million in the nine month period ended September 30, 2014. These tax benefits were recorded as an equity adjustment to additional paid-in capital.

As of September 30, 2014, we had a total of $0.9 million of deferred tax assets for which we had recorded no valuation allowance.  We will continue to assess the level of valuation allowance in future periods.  Should evidence regarding the realizability of tax assets change at a future point in time, the valuation allowance will be adjusted accordingly.

In addition to deferred tax assets carried on our balance sheet, we also had net federal and state research and development credit carryforwards available at December 31, 2013 of $4.9 million and $0.7 million. These credits were not recorded as tax assets as they relate to excess stock compensation deductions that may not be recorded as tax assets under generally accepted accounting principles until the amounts have been utilized to reduce our tax liability. To the extent that these assets are used to reduce future taxes, the benefit will be recorded as a reduction to additional paid-in capital. The aforementioned $1.5 equity adjustment to additional paid-in capital in the nine month period ended September 30, 2014 was related to these deferred tax assets.

In the third quarter of 2014, the Internal Revenue Service commenced an examination of our tax return for the year ended December 31, 2012.

XML

Discontinued Operations

9 Months Ended

Sep. 30, 2014

Discontinued Operations and Disposal Groups [Abstract]

Discontinued Operations

I) Discontinued Operations.  In 2013, we shut down our DSL service assurance software product line, which was previously a component of our DSL Service Assurance Segment. We completed the shutdown in the fourth quarter of 2013 and no longer have any significant continuing involvement with, or cash flows from, this product line. The results of our DSL service assurance software product line have been included in discontinued operations in the consolidated statements of income and comprehensive income. The loss from discontinued operations attributable to the DSL service assurance software product line was (in thousands):

	Three Months Ended September 30,					Nine Months Ended September 30,
	2014		2013			2014		2013
Revenue	$	-	$	156		$	-	$	1,217
Expenses		-		3,355			-		4,866
Loss before income taxes		-		(3,199	)		-		(3,649	)
Income tax benefit		-		1,256			-		1,433
Loss from discontinued operations	$	-	$	(1,943	)	$	-	$	(2,216	)

The consolidated statements of income and comprehensive income for the three and nine months ended September 30, 2013 have been reclassified to reflect the effect of discontinued operations as set forth above.

XML

Patent related income

9 Months Ended

Sep. 30, 2014

Patent Related Income [Abstract]

Patent related income

K) Patent related income.  Patent related income in 2014 and 2013 consists of the following:

Three and nine months ended September 30, 2014.  On July 21, 2014, we entered into an agreement to sell a portion of our patent portfolio pertaining to DSL diagnostic technology for $2.6 million to an unrelated third party. The proceeds from the sale were reduced by $0.5 million of transaction costs, which consisted primarily of fees from the law firm that assisted us in the sale.  The transaction closed on August 1, 2014 and a gain of $2.1 million was included in our financial results for the three and nine months ended September 30, 2014.

The DSL diagnostic technology in the patents we sold in August 2014 was related to our DSL Service Assurance business that we shut down in 2012 and 2013 and reported in discontinued operations in those periods. We do not consider our patent related activities to be a component of the operating business from which the underlying technology was derived, but rather as a component of corporate general and administrative expenses. Accordingly the gain on the sale of these patents was reported in income from continuing operations pursuant to ASC 360, Impairment or Disposal of Long-Lived Assets, and Rule 5-03 of Regulation S-X.

Nine months ended September 30, 2013. In the nine months ended September 30, 2013, we recorded $0.8 million of income from a patent arrangement. We entered into an arrangement with an unaffiliated third party in 2010 under which we assigned certain patents in return for royalties on proceeds from patent monetization efforts by the third party.  Such third party has engaged in various patent monetization activities, including enforcement, litigation and licensing.

We continue to have a contractual relationship with this third party. However, we are unable to predict how much more income we might receive from this arrangement, if any, because:

i)   The claims in one of the patents we assigned were rejected by the United States Patent Office (“USPTO”) in May 2013. The USPTO’s Patent Trial & Appeal Board (“PTAB”) affirmed the USPTO decision in June 2014.  The PTAB decision is currently under appeal to the Federal Circuit, and

ii)   Notwithstanding the outcome in the Federal Circuit, we do not know whether any patent monetization efforts by the third party will be successful.

XML

Discontinued Operations - Loss from discontinued operations attributable to DSL service assurance software product line (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Loss from discontinued operations		$ (1,943)		$ (2,216)
DSL service assurance software product line
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenue		156		1,217
Expenses		3,355		4,866
Loss before income taxes		(3,199)		(3,649)
Income tax benefit		1,256		1,433
Loss from discontinued operations		$ (1,943)		$ (2,216)

XML

Business Segments (Tables)

9 Months Ended

Sep. 30, 2014

Segment Reporting [Abstract]

Schedule of revenues generated from geographic regions

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2014		2013		2014		2013
United States	$	4,154	$	2,529	$	14,945	$	9,323
Saudi Arabia		39		524		117		613
Rest of World		1,834		1,261		4,349		3,784
	$	6,027	$	4,314	$	19,411	$	13,720

Schedule of revenue by product group

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2014		2013		2014		2013
Biometrics	$	5,510	$	3,803	$	17,720	$	11,997
Imaging		369		341		1,065		986
DSL royalties		148		170		626		737
	$	6,027	$	4,314	$	19,411	$	13,720

XML

Inventories - Summary of inventories (Details) (USD $) In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Inventory Disclosure [Abstract]
Raw materials	$ 2	$ 1,584
Finished goods		17
Total	$ 2	$ 1,601

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities:
Net income	$ 4,344	$ 1,011
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	405	325
Stock-based compensation	619	445
Gain on sale of patent assets	(2,127)
Deferred tax provision on other comprehensive income	(44)
(Gain) loss on sale of investments	59	(27)
Loss on disposal of property and equipment		27
Amortization of premium/(discount) on investments	(1)	13
Changes in assets and liabilities:
Accounts receivable	632	703
Receivable from patent arrangement		1,121
Inventories	1,599
Prepaid expenses and other current assets	260	(565)
Deferred tax assets	202	185
Accounts payable	(1,337)	(85)
Accrued expenses, compensation, and professional	58	(261)
Accrued income taxes	57
Due to customers		3,732
Deferred revenue	832	(954)
Net cash provided by operating activities	5,558	5,670
Cash flows from investing activities:
Purchases of property and equipment	(112)	(117)
Proceeds from the sale of property and equipment		24
Purchases of investments		(2,008)
Sales of investments	1,432	1,064
Proceeds from sale of patent assets, net	2,127
Purchase of other assets		(201)
Net cash provided by (used in) investing activities	3,447	(1,238)
Cash flows from financing activities:
Proceeds from issuance of common stock	491	46
Payment of dividends	(39,905)
Excess tax benefits from stock-based compensation	1,461	(63)
Payments made for taxes of employees who surrendered shares related to unrestricted stock	(205)	(71)
Net cash used in financing activities	(38,158)	(88)
Increase/(decrease) in cash and cash equivalents	(29,153)	4,344
Cash and cash equivalents, beginning of period	72,660	71,074
Cash and cash equivalents, end of period	43,507	75,418
Supplemental disclosure:
Cash paid for income taxes	$ 617	$ 535

XML

Stock-Based Compensation

9 Months Ended

Sep. 30, 2014

Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]

Stock-Based Compensation

E) Stock-Based Compensation.  The following table presents stock-based employee compensation expenses included in our unaudited consolidated statements of comprehensive income (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2014		2013		2014		2013
Cost of services	$	15	$	12	$	30	$	23
Research and development		34		26		71		53
Selling and marketing		6		5		12		10
General and administrative		242		174		506		359
Stock-based compensation expense	$	297	$	217	$	619	$	445

Stock Option and SAR Grants. We grant stock options and stock appreciation rights (“SARs”) under our 2001 Nonqualified Stock Plan. We estimate the fair value of stock options and SARs using the Black-Scholes valuation model. This valuation model takes into account the exercise price of the award, as well as a variety of significant assumptions. The assumptions used to estimate the fair value of stock options and SARs include the expected term, the expected volatility of our stock over the expected term, the risk-free interest rate over the expected term, and our expected annual dividend yield. We believe that the valuation technique and the approach utilized to develop the underlying assumptions are appropriate in calculating the fair values of our stock options and SARs. Estimates of fair value are not intended to predict actual future events or the value ultimately realized by persons who receive equity awards.

Unrestricted Stock Grants. We also grant unrestricted shares of stock under our 2001 Nonqualified Stock Plan. Stock-based compensation expense for stock grants is determined based on the fair market value of our stock on the date of grant, provided the number of shares in the grant is fixed on the grant date.

Stock Option and SAR Grant Activity. We did not grant any stock options or SARs in the three and nine month periods ended September 30, 2014 and 2013.

Unrestricted Stock Grant Activity. We granted shares of unrestricted stock in 2014 and 2013 that affected financial results for the three and nine month periods ended September 30, 2014 and 2013. These grants are described below.

2014 Grant.  On March 26, 2014, we granted 152,000 shares of unrestricted stock to directors, officers and employees. The shares are to be issued in two equal installments shortly after June 30, 2014 and December 31, 2014, provided each grantee is serving as a director, officer or employee on those dates. The total stock-based compensation expense related to this grant is $876,000, of which $287,000 and $589,000 were charged to expense in the three and nine months ended September 30, 2014, respectively. We anticipate the remaining $287,000 will be charged to expense in the fourth quarter of 2014.

We issued shares related to the first installment of this grant as follows: 58,769 net shares of common stock were issued in early July 2014 after employees surrendered 17,231 shares for which we paid $113,000 of withholding taxes on their behalf.

2013 Grant.  In April 2013, we granted 130,000 shares of unrestricted stock to directors, officers and employees. The shares were issued in two equal installments shortly after June 30, 2013 and December 31, 2013. We expensed the entire $623,000 stock-based compensation expense related to this grant in the second, third and fourth quarters of 2013. We issued shares of common stock related to this grant as follows: i) 51,374 net shares of common stock were issued in early July 2013 after employees surrendered 13,626 shares for which we paid $71,000 of withholding taxes on their behalf; and ii) 49,936 net shares of common stock were issued in early January 2014 after employees surrendered 15,064 shares for which we paid $92,000 of withholding taxes on their behalf.

XML

Computation of Earnings per Share - Summary of net income per share (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Net income:
Income from continuing operations	$ 2,599	$ 790	$ 4,344	$ 3,227
Loss from discontinued operations		(1,943)		(2,216)
Net income (loss)	$ 2,599	$ (1,153)	$ 4,344	$ 1,011
Shares outstanding:
Weighted-average common shares outstanding (in shares)	22,804	22,571	22,687	22,533
Additional dilutive common stock equivalents (in shares)	89		94	90
Diluted shares outstanding (in shares)	22,893	22,571	22,781	22,623
Basic net income (loss) per share:
Basic net income per share from continuing operations	$ 0.11	$ 0.04	$ 0.19	$ 0.14
Basic net loss per share from discontinued operations (in dollars per share)	$ 0.00	$ (0.09)	$ 0.00	$ (0.10)
Basic net income (loss) per share	$ 0.11	$ (0.05)	$ 0.19	$ 0.04
Diluted net income (loss) per share:
Diluted net income per share from continuing operations	$ 0.11	$ 0.04	$ 0.19	$ 0.14
Diluted net loss per share from discontinued operations	$ 0.00	$ (0.09)	$ 0.00	$ (0.10)
Diluted net income (loss) per share	$ 0.11	$ (0.05)	$ 0.19	$ 0.04

XML

Patent related income (Detail Textuals) (USD $)	3 Months Ended	9 Months Ended		1 Months Ended	3 Months Ended	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2013	Jul. 21, 2014 DSL diagnostic technology	Sep. 30, 2014 DSL diagnostic technology	Sep. 30, 2014 DSL diagnostic technology
Finite-Lived Intangible Assets [Line Items]
Proceeds from sale of portion of patent portfolio				$ 2,600,000
Transaction cost from sale				500,000
Gain on sale of patent assets		2,127,000			2,100,000	2,100,000
Patent related income	$ 2,127,000	$ 2,127,000	$ 780,000

XML

Stock-Based Compensation (Tables)

9 Months Ended

Sep. 30, 2014

Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]

Schedule of stock-based employee compensation expense included in unaudited consolidated statements of comprehensive income

	Three Months Ended September 30,				Nine Months Ended September 30,
	2014		2013		2014		2013
Cost of services	$	15	$	12	$	30	$	23
Research and development		34		26		71		53
Selling and marketing		6		5		12		10
General and administrative		242		174		506		359
Stock-based compensation expense	$	297	$	217	$	619	$	445